Patents by Inventor David Claudie

David Claudie has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction, and other diseases or symptoms
    Patent number: 12233101
    Abstract: The invention relates to therapeutic compositions, solid oral dosage forms, and methods for treating, preventing, or alleviating lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), erectile dysfunction (ED), urinary incontinence, bladder obstruction, overactive bladder (OAB), underactive bladder, interstitial cystitis, prostatitis, bladder and prostate inflammation, prostate fibrosis or pelvic pain. The therapeutic compositions can comprise cranberry powder enriched in cranberry seeds or cranberry seed meal.
    Type: Grant
    Filed: February 28, 2022
    Date of Patent: February 25, 2025
    Assignee: Naturex Inc.
    Inventors: Emilie Annie Claudie Fromentin, Douglas Andrew Klaiber, Daniel David Souza
  • Anti-inflammatory compounds
    Patent number: 9403786
    Abstract: New clerodane compounds isolated from plant material from Dodonaea polyandra are disclosed. The compounds have anti-inflammatory activity. Pharmaceutical and cosmetic compositions containing the compounds, as well as methods of treating inflammation using the compounds, are also disclosed.
    Type: Grant
    Filed: November 10, 2010
    Date of Patent: August 2, 2016
    Assignees: University of South Australia, Chuulangun Aboriginal Corporation
    Inventors: Susan J. Semple, Bradley S. Simpson, Ross Allan McKinnon, David Claudie, Jacobus P. Gerber, Jiping Wang, George Moreton, Sr.
  • ANTI-INFLAMMATORY COMPOUNDS
    Publication number: 20130053437
    Abstract: New clerodane compounds isolated from plant material from Dodonaea polyandra are disclosed. The compounds have anti-inflammatory activity. Pharmaceutical and cosmetic compositions containing the compounds, as well as methods of treating inflammation using the compounds, are also disclosed.
    Type: Application
    Filed: November 10, 2010
    Publication date: February 28, 2013
    Applicants: CHUULANGUN ABORIGINAL CORPORATION, University Of South Australia
    Inventors: Susan J. Semple, Bradley S. Simpson, Ross Allan McKinnon, David Claudie, Jacobus P. Gerber, Jiping Wang